What's breaking now, across thousands of outlets.
(MedPage Today) -- Definium Therapeutics' investigational lysergide (LSD) tablet significantly reduced anxiety in a second phase III trial, meeting the primary and key secondary endpoints, the company announced. Meanwhile, Contineum Therapeutics...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Susie Wiles oversaw Trump’s winning 2024 presidential campaign and has wielded major influence in his second administration.
The New Zealand government website SafeTravel has warned people travelling to Fiji to avoid activities that could increase their risk of HIV infection.
An updated, evidence-based guideline has been developed for the diagnosis and management of childhood nocturnal enuresis (NE). The guideline was published online July 10 in the World Journal of Pediatrics.
Mumbai: A decade of free health screenings conducted during Ganpati by the Eyebetes Foundation has found a high prevalence of undiagnosed diabetes and poor vision among devotees, with the foundation reporting that at least 40% of people above 40 screened were either prediabetic or diabetic.
US Senator Bill Cassidy presses Trump's pick for surgeon general on views over vaccines, public health.
